Equitable Holdings’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$186K Sell
36,800
-19,589
-35% -$99.1K ﹤0.01% 1386
2025
Q1
$298K Buy
56,389
+37,235
+194% +$197K ﹤0.01% 1099
2024
Q4
$129K Buy
+19,154
New +$129K ﹤0.01% 1222